AOD-9604
Typical Dosage
250-500 mcg
Administration
Injection
Half-Life
~30 minutes
Mechanism of Action
Body-composition studies|Lipolysis and adipocyte biology|Metabolic syndrome models|Weight-management research
Research Protocol Summary
Evidence Level
Human Clinical / Investigational
Typical Protocol Duration
4-12 weeks
Species Studied
Human • Mouse • Rat
Administration Schedule
Daily
Studies
Research Availability
Individual PubMed records have not been mapped for this entry yet. Use the linked PubMed search to review the current literature directly.
Related resources
Research Feedback
0 approved
For research discussion only. Community feedback is moderated and shown here as aggregated insights after approval.
Loading approved insights…